(Q45802306)

16 December 2017

title

Travelers with cutaneous leishmaniasis cured without systemic therapy (English)

1 reference

16 December 2017

main subject

cutaneous leishmaniasis

1 reference

M Thellier

4

0 references

author name string

G Morizot

1

1 reference

16 December 2017

E Kendjo

2

1 reference

16 December 2017

O Mouri

3

1 reference

16 December 2017

A Pérignon

5

1 reference

16 December 2017

F Foulet

6

1 reference

16 December 2017

F Cordoliani

7

1 reference

16 December 2017

E Bourrat

8

1 reference

16 December 2017

E Laffitte

9

1 reference

16 December 2017

I Alcaraz

10

1 reference

16 December 2017

N Bodak

11

1 reference

16 December 2017

C Ravel

12

1 reference

16 December 2017

M Vray

13

1 reference

16 December 2017

M Grogl

14

1 reference

16 December 2017

D Mazier

15

1 reference

16 December 2017

E Caumes

16

1 reference

16 December 2017

L Lachaud

17

1 reference

16 December 2017

P A Buffet

18

1 reference

16 December 2017

Cutaneous Leishmaniasis French Study Group

19

1 reference

16 December 2017

language of work or name

English

0 references

publication date

30 April 2013

1 reference

16 December 2017

Clinical Infectious Diseases

published in

1 reference

16 December 2017

volume

57

1 reference

16 December 2017

issue

3

1 reference

16 December 2017

page(s)

370-380

1 reference

16 December 2017

Glucantime injection: benefit versus toxicity

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the New World.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Clinical guidelines for the management of cutaneous leishmaniasis in British military personnel

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

The efficacy of treatment with intralesional meglumine antimoniate alone, compared with that of cryotherapy combined with the meglumine antimoniate or intralesional sodium stibogluconate, in the treatment of cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Treatment of cutaneous leishmaniasis among travellers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Superior efficacy of oral fluconazole 400 mg daily versus oral fluconazole 200 mg daily in the treatment of cutaneous leishmania major infection: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Randomized controlled clinical trial to access efficacy and safety of miltefosine in the treatment of cutaneous leishmaniasis Caused by Leishmania (Viannia) guyanensis in Manaus, Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Consultative meeting to develop a strategy for treatment of cutaneous leishmaniasis. Institute Pasteur, Paris. 13-15 June, 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Recent Developments in Leishmaniasis: Epidemiology, Diagnosis, and Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: a phase 2, randomized, double blind, placebo controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Treatment of cutaneous leishmaniasis in travelers 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Monitoring toxicity associated with parenteral sodium stibogluconate in the day-case management of returned travellers with New World cutaneous leishmaniasis [corrected]

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Should we continue to indicate meglumine antimoniate as first-line treatment for cutaneous leishmaniasis in Tunisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Risk factors for in-hospital mortality of visceral leishmaniasis patients in eastern Uganda

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in East Africa and rationale for switch to liposomal amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Treatment of New World cutaneous leishmaniasis--a systematic review with a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Intralesional antimony for single lesions of bolivian cutaneous leishmaniasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Local or systemic treatment for New World cutaneous leishmaniasis? Re-evaluating the evidence for the risk of mucosal leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

Topical paromomycin with or without gentamicin for cutaneous leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIT269

21 January 2018

Identifiers

DOI

10.1093/CID/CIT269

1 reference

16 December 2017

1 reference

16 December 2017